article · BMC Immunology

NLRP3 (rs10754558) gene polymorphism and tumor necrosis factor alpha as predictors for disease activity and response to methotrexate and adalimumab in psoriasis

20245 citationsOpen accessZagazig University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Psoriasis: Treatment and Pathogenesis
Cytokine Signaling Pathways and Interactions
Autoimmune and Inflammatory Disorders Research

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1186/s12865-024-00630-2

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.